Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Ideas
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Portfolio
News
Enterprise Solutions
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Arrived
EquityMultiple
Follow Us
More
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Premium Newsletters
Smart Value
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Calculators
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
BCYC
Stock Latest News
Ratings
Promising Upside for Bicycle Therapeutics: Buy Rating Backed by Positive Clinical Data and Market Potential for ZP Treatment
14d ago
BCYC
Premium
Ratings
Bicycle Therapeutics: Promising Pipeline Progress and Expansion Opportunities Drive Buy Rating
26d ago
BCYC
Premium
Company Announcements
Bicycle Therapeutics Reports 2024 Progress and Financial Results
27d ago
BCYC
Premium
Ratings
Promising Developments and Strong Financial Position Drive Positive Outlook for Bicycle Therapeutics
27d ago
BCYC
Premium
Ratings
Bicycle Therapeutics: Undervalued Stock with Promising Pipeline and Innovative Platform
27d ago
BCYC
Premium
Ratings
Promising Outlook for Bicycle Therapeutics: Strong Clinical Progress and Financial Health Justify Buy Rating
27d ago
BCYC
Premium
Ratings
Bicycle Therapeutics: Promising Clinical Advances and Strong Financial Position Support Buy Rating
28d ago
BCYC
Premium
The Fly
Bicycle Therapeutics price target lowered to $42 from $53 at Jefferies
28d ago
BCYC
Premium
The Fly
Bicycle Therapeutics reports Q4 EPS (75c), consensus (85c)
28d ago
BCYC
Premium
Company Announcements
Bicycle Therapeutics Reports Promising Trial Results and Future Plans
2M ago
8K
BCYC
Premium
The Fly
Bicycle announces topline data for zelenectide pevedotin plus pembrolizumab
2M ago
BCYC
Premium
The Fly
Bicycle Therapeutics price target lowered to $26 from $32 at JMP Securities
3M ago
BCYC
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
VIR
BCYC
Premium
The Fly
Bicycle Therapeutics price target lowered to $33 from $55 at H.C. Wainwright
3M ago
BCYC
Premium
The Fly
Bicycle Therapeutics price target lowered to $17 from $28 at B. Riley
3M ago
BCYC
Premium
The Fly
Cantor Fitzgerald biotech analysts hold an analyst/industry conference call
3M ago
LLY
ARVN
Premium
The Fly
Cantor Fitzgerald biotech analyst holds an analyst/industry conference call
4M ago
BCYC
Premium
The Fly
Molson Coors upgraded, Rivian downgraded: Wall Street’s top analyst calls
5M ago
HD
SG
Premium
The Fly
Bicycle Therapeutics initiated with an Equal Weight at Stephens
5M ago
BCYC
Premium
The Fly
Stephens sees ‘uphill battle’ for Bicycle Therapeutics, starts at Equal Weight
5M ago
BCYC
Premium
Company Announcements
Bicycle Therapeutics Faces Strategic Risks from Concentrated Shareholder Influence
5M ago
BCYC
Premium
Company Announcements
Bicycle Therapeutics: Promising Q3 Results and Business Progress
5M ago
BCYC
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
